The company is reportedly seen as an attractive acquisition target due to its diversified operations across two segments.

New EU regulations aim to speed up health technology assessments (HTAs), but the pharma industry raises logistical concerns.

Germany’s Merck KGaA is in advanced talks for a potential acquisition of SpringWorks Therapeutics, a U.S. biopharmaceutical ...

Fennec Pharma’s partner Norgine Pharma launches Pedmarqsi in Germany: Monday, February 10, 2025, 14:00 Hrs [IST] Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, ...

PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin ...

Gerresheimer, a German manufacturer specialising in packaging for pharmaceuticals and cosmetics, is reportedly considering a potential sale. The company has engaged advisors to assess interest ...

G2G Bio partners with Boehringer Ingelheim to develop long-lasting injectable drug G2G Bio collaborates with Boehringer Ingelheim to innovate in injectable drug development ...

CDMO Rentschler Biopharma is signalling its intent to cut down cell and gene therapy operations by shutting down its UK ...

A Maryland mom got diagnosed with a condition she didn’t know she had. Then she couldn’t afford the medicine. Now, state ...

Merck KGaA, the German healthcare and technology group, said on Monday it is in advanced talks to acquire U.S. cancer and ...